ContractAsset Purchase Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionEXECUTION VERSION ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of July 5, 2019, by and between siParadigm, LLC, a New Jersey limited liability company (d/b/a siParadigm Diagnostic Informatics), with a principal place of business at 25 Riverside Drive, Pine Brook, NJ 07058 (“Buyer”), and Cancer Genetics Inc., a Delaware corporation, with a principal place of business at Meadows Office Complex, 201 Route 17 North, 2nd Floor, Rutherford, NJ 07070 (“Seller”, and collectively with Buyer, the “Parties” and each a “Party”). WITNESSETH: WHEREAS, Seller provides personalized diagnostics and services that enable precision medicine in the field of oncology, including clinical lab testing services that provides critical genomic information used for patients and physicians to diagnose, monitor and inform cancer treatment; WHEREAS, Buyer is a specialized reference laboratory with expertise in hematopathology and oncology diagnostics, offering next-generation se
At the Closing (as hereinafter defined), upon the terms and conditions set forth in this Agreement, Seller shall sell, convey pursuant to and as evidenced by the Assignment and Assumption and Bill of Sale (as hereinafter defined), set over, assign,...Asset Purchase Agreement • August 19th, 2019 • Cancer Genetics, Inc • Services-medical laboratories • New Jersey
Contract Type FiledAugust 19th, 2019 Company Industry Jurisdiction